Edition:
United Kingdom

BeyondSpring Inc (BYSI.OQ)

BYSI.OQ on NASDAQ Stock Exchange Capital Market

20.00USD
18 Oct 2018
Change (% chg)

$0.23 (+1.16%)
Prev Close
$19.77
Open
$19.64
Day's High
$20.00
Day's Low
$19.64
Volume
739
Avg. Vol
2,454
52-wk High
$37.70
52-wk Low
$19.20

Chart for

About

BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $892.10
Shares Outstanding(Mil.): 22.84
Dividend: --
Yield (%): --

Financials

  BYSI.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -3.97 -- --
ROI: -268.89 0.58 14.30
ROE: -260.45 1.62 16.03

Earnings vs. Estimates